Table 1 Clinical and pathological characteristics
Characteristics | n (%) or Means ± SD |
|---|---|
Sex | |
 Male | 703 (76.1%) |
 Female | 221 (23.9%) |
Age, yrs. | 60.9 ± 11.2 |
Body mass index (kg/m2) | 21.9 ± 3.3 |
ASA scores | |
 1 | 335 (38.4%) |
 2 | 536 (58%) |
 3 | 33 (3.6%) |
Comorbidities | |
 Yes | 249 (26.9%) |
 No | 675 (73.1%) |
Tumor location | |
 Upper | 221 (23.9%) |
 Middle | 153 (16.6%) |
 Lower | 440 (47.6%) |
 Mix | 110 (11.9%) |
WHR | 3.2 ± 2.1 |
PLR | 153.7 ± 77.6 |
LMR | 4.4 ± 1.9 |
NLR | 2.6 ± 2.2 |
Type of surgery | |
 Total gastrectomy | 447 (48.4%) |
 Partial gastrectomy | 477 (51.6%) |
Tumor size (cm) | 4.6 ± 2.5 |
Adjuvant chemotherapy | |
 Yes | 408 (44.2%) |
 No | 516 (55.8%) |
Pathological T stage | |
 T1 | 232 (25.1%) |
 T2 | 101 (10.9%) |
 T3 | 279 (30.2%) |
 T4a | 312 (33.8%) |
Pathological N stage | |
 N0 | 359 (38.9%) |
 N1 | 134 (14.5%) |
 N2 | 143 (15.5%) |
 N3 | 288 (31.2%) |
Pathological TNM stage | |
 IA | 195 (21.1%) |
 IB | 72 (7.8%) |
 IIA | 117 (12.7%) |
 IIB | 104 (11.3%) |
 IIIA | 98 (10.6%) |
 IIIB | 159 (17.2%) |
 IIIC | 179 (19.4%) |